Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 960151-65-9
2. Lu Aa24530 (hbr)
3. Tedatioxetine Hydrobromide [usan]
4. Tedatioxetine (hydrobromide)
5. 986rnr3cfm
6. 4-[2-(4-methylphenyl)sulfanylphenyl]piperidine;hydrobromide
7. Tedatioxetine Hydrobromide (usan)
8. Piperidine, 4-(2-((4-methylphenyl)thio)phenyl)-, Hydrobromide (1:1)
9. Unii-986rnr3cfm
10. Schembl1741722
11. Chembl2107377
12. Lu Aa 24530 Hydrobromide
13. Cs-6846
14. Tedatioxetine Hydrobromide [who-dd]
15. Hy-101755
16. D10171
17. 4-(2-(4-tolylsulfanyl)phenyl)-piperidin Hydrobromide
18. Q27272091
19. 4-(2-((4-methylphenyl)sulfanyl)phenyl)piperidine Hydrobromide
| Molecular Weight | 364.3 g/mol |
|---|---|
| Molecular Formula | C18H22BrNS |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 3 |
| Exact Mass | 363.06563 g/mol |
| Monoisotopic Mass | 363.06563 g/mol |
| Topological Polar Surface Area | 37.3 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 279 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Tedatioxetine Hydrobromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tedatioxetine Hydrobromide, including repackagers and relabelers. The FDA regulates Tedatioxetine Hydrobromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tedatioxetine Hydrobromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tedatioxetine Hydrobromide supplier is an individual or a company that provides Tedatioxetine Hydrobromide active pharmaceutical ingredient (API) or Tedatioxetine Hydrobromide finished formulations upon request. The Tedatioxetine Hydrobromide suppliers may include Tedatioxetine Hydrobromide API manufacturers, exporters, distributors and traders.
click here to find a list of Tedatioxetine Hydrobromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tedatioxetine Hydrobromide DMF (Drug Master File) is a document detailing the whole manufacturing process of Tedatioxetine Hydrobromide active pharmaceutical ingredient (API) in detail. Different forms of Tedatioxetine Hydrobromide DMFs exist exist since differing nations have different regulations, such as Tedatioxetine Hydrobromide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tedatioxetine Hydrobromide DMF submitted to regulatory agencies in the US is known as a USDMF. Tedatioxetine Hydrobromide USDMF includes data on Tedatioxetine Hydrobromide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tedatioxetine Hydrobromide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tedatioxetine Hydrobromide suppliers with USDMF on PharmaCompass.
Tedatioxetine Hydrobromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tedatioxetine Hydrobromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tedatioxetine Hydrobromide GMP manufacturer or Tedatioxetine Hydrobromide GMP API supplier for your needs.
A Tedatioxetine Hydrobromide CoA (Certificate of Analysis) is a formal document that attests to Tedatioxetine Hydrobromide's compliance with Tedatioxetine Hydrobromide specifications and serves as a tool for batch-level quality control.
Tedatioxetine Hydrobromide CoA mostly includes findings from lab analyses of a specific batch. For each Tedatioxetine Hydrobromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tedatioxetine Hydrobromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Tedatioxetine Hydrobromide EP), Tedatioxetine Hydrobromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tedatioxetine Hydrobromide USP).
LOOKING FOR A SUPPLIER?
